A recent article reported that elevated levels of CTRP15 were observed in CAD patients, and its correlation with insulin resistance and inflammation might be the result of a compensatory mechanism for metabolic dysfunctions in CAD [26]. This evidence concerns the gene ERFE and Insulin resistance.